Five-year plan to transform hospital pharmacy services in Wales
A new five-year plan to revolutionize hospital pharmacy services in Wales has been approved by Health and Social Services Minister Vaughan Gething. The plan will transform the way some of the most innovative and life-saving drugs are prepared, including cancer therapies, intravenous antibiotics and parenteral nutrition.
The Transforming Access to Medicines program is a five-year plan for which the Minister has asked the NHS Wales Shares Services Partnership (NWSSP) to develop a business case with an indicative funding requirement of Â£ 67million.
Sterile drug preparation, also referred to as aseptic services, is a specialty within hospital pharmacy services. Aseptic services are responsible for the development, preparation and delivery of unique patient-centered drugs, including the preparation of injectable systemic cancer therapy (SACT), preparation of parenteral (intravenous) nutrition for people with medical condition prevents them from absorbing nutrients from the foods they consume and radiopharmaceuticals used in the diagnosis and treatment of cancer.
With the advancement of drugs that improve patient outcomes, the demand for these essential services has increased. Currently much of this work is undertaken in hospitals in Wales.
In order to expand its services, the NWSSP will develop business cases for the creation of three new integrated regional facilities based in North, South West and South East Wales. While the exact funding required will be confirmed as the business cases are developed, an indicative funding requirement of Â£ 67million has been identified.
The three regional facilities will increase the capacity and capacity of the NHS Wales to prepare the medicines people need and allow the NHS to capitalize on advances in technology and automation, improving patient safety and freeing up the time of doctors. nurses for patient care.
Along with the new facilities, the investment will support the transformation of the workforce, the creation of new skilled jobs and the increase in productivity. The funding will also create opportunities for collaboration between the NHS and universities supporting clinical trials and research into the development of innovative products that allow drugs to be delivered in or near the home, rather than in the hospital. .
Minister of Health and Human Services, Vaughan Gething said; âThe regional facilities will be the first of their kind in the UK and will offer enormous benefits, not only for existing medical treatments, but also for the development and research of new treatments. The funding will invest in the future workforce and develop skills vital for a service that is experiencing increasing demand. The plans announced today will further support access to innovative medicines for patients in Wales through our new treatment fund and strengthen our commitment to ensuring people in Wales have timely access to the latest and greatest treatments and the best.
Neil Frow, Managing Director of the NHS Wales Shared Services Partnership (NWSSP): âI salute the Minister by confirming his support for this ambitious program which is a major investment over the next 5 years. This is a fantastic example of how health boards and trusts come together under the shared services partnership to work together to improve patients in Wales. Over the next few years, the development of new hubs will play a key role in developing the capacity and ability to meet current and future service needs.